Open access · CC-BY
via OpenAlex
Metformin decreases progerin expression and alleviates pathological defects of Hutchinson–Gilford progeria syndrome cells
Anne-Laure Egesipe, Sophie Blondel, Alessandra Lo Cicero, Anne-Laure Jaskowiak, Claire Navarro, Annachiara De Sandre‐Giovannoli, Nicolas Lévy, Marc Peschanski, Xavier Nissan
npj Aging and Mechanisms of Disease · 2016 · ▲ 60 citations
Abstract
Abstract Hutchinson–Gilford progeria syndrome (HGPS) is a rare genetic disorder that causes systemic accelerated aging in children. This syndrome is due to a mutation in the LMNA gene that leads to the production of a truncated and toxic form of lamin A called progerin. Because the balance between the A-type lamins is controlled by the RNA-binding protein SRSF1, we have hypothesized that its inhibition may have therapeutic effects for HGPS. For this purpose, we evaluated the antidiabetic drug metformin and demonstrated that 48 h treatment with 5 mmol/l metformin decreases SRSF1 and progerin expression in mesenchymal stem cells derived from HGPS induced pluripotent stem cells (HGPS MSCs). The effect of metformin on progerin was then confirmed in several in vitro models of HGPS, i.e., human primary HGPS fibroblasts, LmnaG609G/G609G mouse fibroblasts and healthy MSCs previously treated with a PMO (phosphorodiamidate morpholino oligonucleotide) that induces progerin. This was accompanied by an improvement in two in vitro phenotypes associated with the disease: nuclear shape abnormalities and premature osteoblastic differentiation of HGPS MSCs. Overall, these results suggest a novel approach towards therapeutics for HGPS that can be added to the currently assayed treatments that target other molecular defects associated with the disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/npjamd.2016.26
- Canonical
- link ↗
- Fetched
- 2026-09-20 MST
Cite this
APA
Egesipe, A., Blondel, S., Cicero, A.L., Jaskowiak, A., Navarro, C., Sandre‐Giovannoli, A.D., Lévy, N., Peschanski, M., & Nissan, X. (2016). Metformin decreases progerin expression and alleviates pathological defects of Hutchinson–Gilford progeria syndrome cells. <em>npj Aging and Mechanisms of Disease</em>. https://doi.org/10.1038/npjamd.2016.26
Vancouver
Egesipe A, Blondel S, Cicero AL, Jaskowiak A, Navarro C, Sandre‐Giovannoli AD, et al. Metformin decreases progerin expression and alleviates pathological defects of Hutchinson–Gilford progeria syndrome cells. npj Aging and Mechanisms of Disease. 2016. doi:10.1038/npjamd.2016.26.
BibTeX
@article{annelaure2016Metfor,
title = {Metformin decreases progerin expression and alleviates pathological defects of Hutchinson–Gilford progeria syndrome cells},
author = {Anne-Laure Egesipe and Sophie Blondel and Alessandra Lo Cicero and Anne-Laure Jaskowiak and Claire Navarro and Annachiara De Sandre‐Giovannoli and Nicolas Lévy and Marc Peschanski and Xavier Nissan},
journal = {npj Aging and Mechanisms of Disease},
year = {2016},
doi = {10.1038/npjamd.2016.26},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging Cell 2024
Open access · CC-BY
A longevity‐specific bank of induced pluripotent stem cells from centenarians and their offspring
Current Genetic Medicine Reports 2022
Preprint · OA
Genetic, Social, and Lifestyle Drivers of Healthy Aging and Longevity
biorxiv 2024
Preprint · CC-BY
A longevity-specific bank of induced pluripotent stem cells from centenarians and their offspring
Scientific Reports 2024
Open access · CC-BY
Lack of association between common polymorphisms associated with successful aging and longevity in the population of Sardinian Blue Zone
Scientific reports 2024
Open access · OA
Lack of association between common polymorphisms associated with successful aging and longevity in the population of Sardinian Blue Zone.
Aging Cell 2024
Open access · CC-BY